Early COVID-19 Pandemic Response in Western Visayas, Philippines
medrxiv(2022)
Abstract
The COVID-19 pandemic has burdened the public health system in the Philippines since January 2020. In Western Visayas (Region 6), Philippines, issues have been raised on the limitations of the government’s response on testing, contact tracing, and augmentation of healthcare facilities. Using data from the Western Visayas - Regional Epidemiologic Surveillance Unit (WV - RESU) from March 20 – June 20, 2020, the following observations were made: 1) Of the 6 provinces, Iloilo had the highest % tests done per capita which may be linked to the presence of the only regional COVID-19 testing facility in the province at that time, 2) There were delays in the overall processing times for specimens from Antique and Negros Occidental which may be linked to transport logistics and/or laboratory processing, 3) Contact tracing and testing were de-linked – tracing was adequate (3,420/3,503, 97.63%), but less than 50% of these (1,668/3,420) were tested, 4) Hospital and quarantine facility capacities were still adequate, but their utilization rates needed to be monitored continuously for further augmentation, if needed. This data shows the challenges of establishing a pandemic response in one of the regions in the Philippines.
### Competing Interest Statement
The authors have declared no competing interest.
### Funding Statement
This study has no commercial or non-commercial funding source to disclose.
### Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study has been reviewed and approved by the University of San Agustin Research Ethics Review Committee.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
All data included in the analysis may be accessed in the Supplementary Information appendices.
MoreTranslated text
Key words
pandemic,philippines,western visayas
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined